Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

Abstract

AIMS Risk of Type 2 diabetes varies by ethnicity, but whether ethnicity remains important among those who have impaired glucose tolerance or impaired fasting glucose is uncertain. Whether the effect of thiazolidinedione treatment on diabetes prevention in persons with non-diabetic dysglycaemia varies by ethnicity is also not known. We addressed these… (More)
DOI: 10.1111/j.1464-5491.2010.03064.x

Topics

Cite this paper

@article{Boyko2010EffectsOE, title={Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.}, author={Edward John Boyko and H. C. Gerstein and V. Mohan and Shehu Mohammed Yusuf and P. Sheridan and S. Anand and Jonathan Shaw}, journal={Diabetic medicine : a journal of the British Diabetic Association}, year={2010}, volume={27 11}, pages={1226-32} }